首页> 外文会议>International Conference on Advanced Nanomaterials and Emerging Engineering Technologies >Evaluation of effectiveness of polymeric nanoparticles based vaccine delivery system over varying time intervals using tetanus toxoid as model antigen
【24h】

Evaluation of effectiveness of polymeric nanoparticles based vaccine delivery system over varying time intervals using tetanus toxoid as model antigen

机译:基于聚合物纳米粒子的疫苗递送系统的效果评价在不同时间间隔用Tetanus类毒素作为模型抗原

获取原文

摘要

At present choice of adjuvants for human vaccination reflects a compromise between a requirement for adjuvanticity and an acceptable level of side-effects. To overcome the side effects, encapsulation of antigen in the biodegradable polymeric nanoparticles (NPs) may be a promising approach, which may be developed as adjuvants. Moreover, small size of these nano-formulations may help to project the antigen directly to the antigen presenting cells (APCs) for stimulating cell mediate immunity. The present study was directed towards the evaluation of PLA and PCL based nanoformulations as potential adjuvants by using tetanus toxoid as model antigen. The particles size was observed in the range from 92.9 ± 2.6 to 124.6 ± 3.7 nm having zeta potential of −12.4 ± 1.2 to −3.4 ± 1.5. The loading efficiency of different formulations ranges from 46.3 – 56.8 %. Highest loading of 56.8% and burst release (82 % in 48 days) was observed in PLA-PEG based nanoformulation. In terms of anti-tetanus antibodies (determined by ELISA) titer of > 0.5 IU/ml was observed upto 70 days in all the survived mice. Efficacy of nanoformulations was studied in mice by challenge method over different time intervals wherein tetanus loaded PLA, PLA-PEG and PCL NPs shows maximum efficacy at 28, 56 and 21 days respectively. The study shows that the biodegradable nanoparticle based formulations has no toxicity, comparable efficacy and therefore has a strong potential as vaccine adjuvant and delivery system.
机译:目前为人类疫苗选择的佐剂反映了佐治要求与可接受的副作用水平之间的折衷。为了克服副作用,可生物降解的聚合物纳米颗粒(NPS)中的抗原的封装可以是有希望的方法,其可以作为佐剂开发。此外,这些纳米制剂的小尺寸可以有助于将抗原直接突出到抗原呈递细胞(APC)以刺激细胞介导免疫。本研究旨在通过使用破伤风类毒素作为模型抗原来评估PLA和PCL基纳米族种子作为潜在佐剂。观察到颗粒尺寸在92.9&#x00b1的范围内; 2.6到124.6± 3.7 nm具有zeta潜力的− 12.4± 1.2到− 3.4± 1.5。不同配方的加载效率范围为46.3-56.8%。在PLA-PEG的纳米型纳米型型纳米型中,观察到最高负荷56.8%和突发释放(48天内的82%)。就抗破伤风抗体(由ELISA测定)滴度滴度>在所有存活的小鼠中观察到0.5 iu / ml的达70天。通过在不同的时间间隔中通过攻击方法在小鼠中研究了纳米族种质的疗效,其中Tetanus负载PLA,PLA-PEG和PCL NPS分别显示出在28,56和21天的最大疗效。该研究表明,可生物降解的纳米颗粒基配方没有毒性,可比性效果,因此具有强大的潜力作为疫苗辅助和递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号